Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal dispute

2

By Bhanvi Satija and Mariam Sunny Oct 1 (Reuters) – Sanofi and Regeneron said on Thursday they will develop four new drugs together in a deal worth up to $8 billion and settle prior litigation, moves

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)